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Purpose: Even though hypospadias is one of the most common congenital anomalies, 
the cause of hypospadias is largely unknown. With regard to molecular biology and mi-
croarray technology, it appears that hypospadias is potentially related to disrupted 
gene expression. Genomic analysis of hypospadiac tissue indicated a potential role for 
activating transcription factor 3 (ATF3)  in the development of this anomaly. This study 
prospectively examined the expression of ATF3 in tissues from 20 children with hypo-
spadias compared with 26 normal penile skin tissue samples from elective circumcision.
Materials and Methods: Prepucial tissue was obtained from children who underwent 
repair of hypospadias for comparison with tissue samples from children who underwent 
elective circumcision. Skin specimens were evaluated for the expression of ATF3 pro-
tein by immunohistochemical staining.
Results: Immunohistochemical staining for ATF3 in samples from children who under-
went repair of hypospadias was significantly greater than in samples from children who 
underwent elective circumcision (80% vs. 11%, respectively; p＜0.05).
Conclusions: Our results indicate that ATF3 is up-regulated in the penile skin tissue 
of boys with hypospadias, which suggests a role for this transcription factor in the devel-
opment of this abnormality.
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INTRODUCTION
Hypospadias is defined as an ectopic urethral meatus on 
the ventral aspect of the penis, scrotum, or perineum with 
or without ventral penile curvature, and estimates of its 
prevalance range from 3 to 8 cases per 1,000 male births 
[1-3]. Its etiology is incompletely understood. Hypospadias 
probably has a multifactorial origin that involves the ac-
tions of environmental factors and endocrine-active com-
pounds against a genetic backdrop, although few molec-
ular and mechanistic studies have been done [4,5].
　Activating transcription factor 3 (ATF3) is a member of 
the ATF/cAMP responsive element binding (CREB) family 
[6]. ATF3 may be involved in homeostasis, wound healing, 
cell adhesion, cancer cell invasion, apoptosis, and signaling 
pathways [7,8]. Overexpression of ATF3 protein sup-
presses cell growth and slows the transition of cells from 
G1 to S phase. This evidence suggests that the ATF3 pro-
tein may play a negative role in cell cycle progression [9,10]. 
Microarray results indicate that ATF3 is one of the genes 
that is upregulated in hypospadiac tissue [11,12]. 
　In this study, the role of expression of ATF3 protein was 
investigated in the etiology of hypospadias.
MATERIALS AND METHODS
Following ınstitutional review board approval, informed 
consent was received from parents. Twenty-five males 
aged between 5 and 9 years (mean: 7.4 years) with hypo-
spadias who were scheduled to undergo surgical repair 
were prospectively entered into the study from December 
2008 to June 2009. Patients with an undescended testis, Korean J Urol 2010;51:561-564
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TABLE 1. Clinical features of all patients with hypospadias
Type No. of patients
Mild 
Coronal 5
 Subcoranal  9
Moderate
 Distal 4
 Midshaft 2
TABLE 2.  Expression of ATF3 protein
Tissue IHC positive IHC negative Total p-value
Hypospadiac  16 (8%)   4 (20%) 20
 sample
＜0.05
Control   3 (11%) 23 (89%) 26
 sample
ATF3: activating transcription factor 3, IHC: immunohistochem-
ical
FIG. 1. Activating transcription factor 3 (ATF3) immunoreactivity in hypospadic and control tissues (x100). (A) There is no ATF3 
immunoreactivity in circumcision control tissue. (B) ATF3 is clearly expressed in the nucleous of the cell (arrow) in the sc tissue of 
subcoronal hypospadic sample. (C) ATF3 protein localized in the nuclei of stromal cells (black arrow) and the vascular endothelium
(white arrow) in sc tissue of mid penil hypospadic sample.
intersex condition, or known endocrine abnormalities; who 
had undergone testosterone replacement therapy pre-
operatively; or who had a family history of hypospadias or 
a maternal age higher than 35 at the time of birth were ex-
cluded from the study. The position of the urethral meatus 
was assessed according to the Ducket clasification by a sin-
gle surgeon [13]. Excess prepucial tissue was obtained from 
ethnically comparable boys at the time of elective surgery 
for hypospadias. Controls consisted of 26 patients aged be-
tween 6 and 11 years (mean: 8.3 years) undergoing elective 
circumsicion. Tissue specimens were prepared for paraf-
in-embedded or frozen sectioning. We included only cases 
from Turkey and controls living in the same area.
1. Antibodies and immunohistochemical techniques
Skin specimens were evaluated for the expression of ATF3 
protein by immunohistochemical staining by use of the 
standard protocol accompanying the ABC kit (Vector Labo-
ratories, Inc., CA, USA) with overnight primary-antibody 
incubation with rabbit-anti-ATF3 (Santa Cruz Biotechnology, 
Inc., CA, USA) at a dilution of 1:400. Control sections were 
incubated without primary antibody. Specimens were ex-
amined under light microscopy with hemotoxylen dye by 
two independent pathologists blinded to the specimens. 
　Nuclear ATF3 immunoreactivity was considered abnor-
mal when samples demonstrated more than 20% nuclear 
reactivity. If the immunoreactivity of the specimen was 
greater than 50%, it was recorded as strong intensity by the 
agreement of two observers.
2. Statistical analysis
Fisher’s exact two-tailed tests were used to compare the fre-
quency data of the two groups. Statistical significance was 
assigned at p＜0.05. To evaluate inter- and intraobserver 
agreement on immunohistochemical analysis, Cohen kap-
pa statistical analysis was performed by using SPSS for 
Windows version 15.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
Forty-six patients were enrolled in this study. Five of the 
25 hypospadiac patients were excluded because of a history 
of previous orchidopexy, testosterone replacement ther-
apy, or diagnosed concomitant undescended testis. The lo-
cation of the meatus in the hypospadiac patients is pre-
sented in Table 1. None of the hypospadiac patients had a 
proximally located meatus (Table 1).
　ATF3 protein was localized in the nuclei of stromal cells 
and the vascular endothelium in the subcutaneous tissue 
of the prepuce. All of the patients had dorsal prepitual skin. 
Of the 46 specimens examined by immunohistochemistry, 
16 (80%) of the 20 patients with hypospadias showed ex-
pression of ATF3 protein, and only 3 (11%) of the 26 patients 
undergoing circumcision stained positive (p＜0.05) (Table Korean J Urol 2010;51:561-564
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TABLE 3. Expression of ATF3 protein in hypospadiac samples
      Location of  IHC IHC
p-value
hypospadiac meatus positive negative
Coronal 4 1 p＞0.05
Subcoranal 7 2
Distal 3 1
Midshaft 2 0
ATF3: activating transcription factor 3, IHC: immunohistoche-
mical
2). Intra- and interobserver agreement was excellent with 
kappa (Cohen statistics) values of 0.88 and 0.80, respec-
tively.
　The immunoreactivity of expression of ATF3 protein in 
normal tissue and in a hypospadiac sample are shown in 
Fig. 1. The staining intensities were 6.9 times as strong in 
patients in the hypospadiac group as in the control group 
(RR: 6.933, 95% CI: 2.3-11.2). The staining intensities were 
found to be similiar in patients with distal and middle hypo-
spadias (p＞0.05) (Table 3). Strong staining intensities 
were found in 2 patients with a meatus located midshaft, 
whereas strong staining intensities were found in 2 pa-
tients with a distally located urethral meatus.
DISCUSSION
The development of the male external genitalia is a com-
plex process, comprising genetic programming, cell differ-
entiation, hormonal signaling, enzyme activity, and tissue 
remodeling, which follows an orderly sequence, occurring 
in a time- and concentration-dependent manner [14]. Any 
disturbance in these processes can lead to hypospadias. 
The cause of hypospadias is largely unknown, however. 
Several etiologies for hypospadias have been suggested, in-
cluding genetic, endocrine, and environmental factors 
[4,5].
　There are conflicting results in the literature about the 
association between ATF3 and hypospadias. The first hu-
man study to demonstrate a relationship between ATF3 
and hypospadias was performed by Liu et al [15]. Immuno-
histochemical analysis of human foreskin demonstrated 
that 86% of the hypospadias samples were positive for the 
expression of ATF3, whereas only 13% of those from normal 
tissues were positive in their study. Beleza-Meireles et al 
analyzed DNA from 330 boys with nonsyndromic hypo-
spadias [16]. ATF3 as a hormone-responsive gene has been 
shown to be related to the etiology of hypospadias. However, 
it is a well-known fact that most associations reported in 
genetic studies do not replicate across subsequent studies 
[17]. van der Zanden et al were unable to replicate the re-
sults of earlier studies [18]. Analyzed populations in men-
tioned studies were indeed dissimilar, and some of the pop-
ulations even differed in ethnicity. We included only a 
Turkish population in this study.
　This study demonstrated that ATF3 protein was overex-
pressed in an ethnically similiar hypospadiac pediatric age 
group. Conventional manual immunohistochemical meth-
ods were used because of cost, time, and space consid-
erations to detect abnormal immunoreactivity. The cutoff 
point was chosen as 20% for abnormal immunoreactivity 
because sequential testing of different cutoffs from 0% to 
95% in 5% increments revealed that 20% was the best cutoff 
for abnormal protein expression. The staining intensities 
appeared to be stronger in patients with more severe hypo-
spadias than in those with mild hypospadias. All patients 
with a midshaft-located urethral meatus showed stronger 
intensities, whereas 3 of 18 distal hypospadiac patients 
showed strong intensities of ATF3 protein expression.
　Most of the hypospadiac patients in this study were re-
corded as having a mild degree of hypospadias, and there 
were no patients with a proximally located meatus. The 
staining intensities were found to be stronger in patients 
in the hypospadiac group than in the control group. ATF3 
overexpression may have been related to the severity of hy-
pospadias in our study. None of the hypospadiac patients 
with a coronal or subcoranal meatus showed strong stain-
ing intensities. However, all of the hypospadiac patients 
with a midshaft-located meatus showed strong staining 
intensities. 
　There may be a difference in the etiology of hypospadias 
in different populations. A growing body of evidence sug-
gests that the development of hypospadias has a two-hit 
etiology involving a genetic predisposition coupled with fetal 
exposure to an environmental disruptor [14]. Endocrine- 
related genes, namely androgen receptor gene (AR), encod-
ing estrogen receptor 1 (ESR1) and ATF3, have been asso-
ciated with hypospadias in previous studies [16,19,20]. 
However, the numbers of samples analyzed in these stud-
ies were relatively small. In a large study population, four 
single-nucleotide polymorphism genes including ATF3 
were investigated by van der Zanden et al [18]. They were 
unable to show an association between hyospadias and 
ATF3. Differences in results between their and previous 
studies may also have been caused by disease hetero-
geneity due to differences in the criteria used to select the 
cases. In this study, we strictly excluded factors suspected 
to be of relevance in the etiology of hypospadias. Population 
stratification, which occurs when cases and controls are 
drawn from different subgroups that differ in disease prev-
alence and frequency of the genetic variant, may lead to 
spurious results. We selected only cases and controls living 
in the same area in Turkey to minimize the chance of pop-
ulation stratification.
　The current study is not devoid of limitations. The power 
of our conclusion may be somewhat limited by the small 
study population. The clinical application of immunohisto-
chemistry has been limited by discrepancies related to var-
iability in the interpretation and stratification criteria and 
inconsistency in specimen handling and technical pro-
cedures. However, two blinded pathologists graded the 
blocks to minimize interpreter-related variability in this 
study. An automated immunostaining (ACIS) platform Korean J Urol 2010;51:561-564
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and quantitative imaging may also help to minimize tech-
nique-related variability, but the major drawback to this 
technology is the apparent lack of an agreed-on or clearly 
described standard ACIS scoring method. 
CONCLUSIONS
Our results indicate that ATF3 is up-regulated in the pen-
ile skin tissues of boys with hypospadias, which suggests 
a role for this transcription factor in the development of this 
abnormality.
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